Delivery Order SPE2DB20D1051-SPE2DB24FD7EP
Award Date 3/1/24
Potential Completion Date 3/4/24
Potential Value $3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of ENGERIX-B 20 MCG/ML SYRNML vaccines. The contract has a completion date of March 4, 2024 and a potential value of $1,992.72. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range...
- The Defense Logistics Agency (DLA) awarded a $2,816.86 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of 4,565,699,051 units of the ENGERIX-B 20 MCG/ML SYRNML vaccine. This delivery order was placed against an Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which serves as a primary vehicle for providing pharmaceutical and medical supplies to support military...
- The Defense Logistics Agency (DLA) awarded a $3,195.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency (DLA) awarded a $3,964.77 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has an ultimate completion date of April 24, 2024 and was awarded on April 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $1,890.02 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine products. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceuticals. The contract has a ceiling value of $18,002.34 and a period of performance through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp, which serves...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor and prime contractor, to provide ENGERIX-B 20 MCG/ML SYRNML to support military treatment programs and facilities. The $1,660.60 contract has a completion date of March 6, 2024 and does not include a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, holds an indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,967.56 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support military treatment programs and facilities. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $3,387.40 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a prescription medication, with a completion date of June 7, 2024. This award is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a potential value of $2,685.51 and a completion date of February 12, 2024. This award is not associated with any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up...